Two years after spinning off its $15 billion consumer health unit as Kenvue, Johnson & Johnson is slimming down again by ...

J&J CEO Joaquin Duato told investors this week that the orthopedics spinoff would allow J&J to focus on faster-growing ...

Johnson & Johnson’s plans to spin off its orthopedics business is underway, and the move is expected to, leaders said in its third quarter 2025 earnings call. “We continue to invest at industry ...

CEO Joaquin Duato said the spinout will help the healthcare giant focus on medtech areas with higher growth and margins, such ...

Staff at the Cork branch of Johnson & Johnson's orthopaedics subsidiary DePuy Synthes have been informed of its parent company's intent to separate it into a standalone business.

Johnson & Johnson said on Tuesday it plans to separate its orthopedics business into a standalone company within the next 18 ...

The planned separation is the latest move by J&J to slim down in recent years and focus on faster-growing businesses.

DePuy Synthes has a well established reputation in the inpatient and hospital outpatient department setting. Now, the company is developing a new focus on freestanding ambulatory surgery centers: ...

RAYNHAM, Mass., Aug. 25, 2021 /PRNewswire/ -- The Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes,** The Orthopaedics Company of Johnson & Johnson, will feature new products ...

Johnson's ($JNJ) DePuy Synthes unit is facing regulators' ire as the FDA slapped the company's recall of its jaw-stabilizing device with a Class I label, its most ...

RAYNHAM, Mass., Aug. 18, 2021 /PRNewswire/ -- Today, The Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson,** introduces the ...

PALM BEACH GARDENS, Fla., Nov. 22, 2021 /PRNewswire/ -- DePuy Synthes, The Orthopaedics Company of Johnson & Johnson*, has launched the UNIUM™ System as the newest addition to its Power Tools ...